[1. Goltzman D, Cole DEC. Hypoparathyroidism. In: Primer on the metabolic bone diseases and disorders of mineral metabolism, 6th ed, Favus MJ (Ed), American Society of Bone and Mineral Research, Washington, DC 2006.p.216.]Search in Google Scholar
[2. Rita Rastogi, Norman J. Beauchamp, Paul W. Ladenson, Calcification of the Basal Ganglia in Chronic Hypoparathyroidism, The Journal of Clinical Endocrinology & Metabolism, Volume 88, Issue 4, 1 April 2003, Pages 1476–1477.10.1210/jc.2002-021804]Open DOISearch in Google Scholar
[3. Rubin MR, Levine MA. Hypoparathyroidism and pseudohypoparathyroidism. In Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 8th ed, Rosen CJ (Ed), American Society of Bone and Mineral Research, Ames, Iowa 2013. p.579.10.1002/9781118453926.ch72]Search in Google Scholar
[4. New Directions in Treatment of Hypoparathyroidism. Tabacco G, Bilezikian JP. Endocrinol Metab Clin North Am. 2018;47(4):901.10.1016/j.ecl.2018.07.013]Open DOISearch in Google Scholar
[5. Sikjaer, T., Rejnmark, L., Rolighed, L., Heickendorff, L., Mosekilde, L. and, (2011), The effect of adding PTH(1–84) to conventional treatment of hypoparathyroidism: A randomized, placebo-controlled study. J Bone Miner Res, 26: 2358-2370. doi:10.1002/jbmr.47010.1002/jbmr.470]Open DOISearch in Google Scholar
[6. Defect of receptor-cyclase coupling protein in psudohypoparathyroidism. Farfel Z, Brickman AS, Kaslow HR, Brothers VM, Bourne HR. N Engl J Med. 1980;303(5):237.10.1056/NEJM198007313030501]Search in Google Scholar
[7. Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein. Levine MA, Downs RW Jr, Moses AM, Breslau NA, Marx SJ, Lasker RD, Rizzoli RE, Aurbach GD, Spiegel AM. Am J Med. 1983;74(4):545.10.1016/0002-9343(83)91008-2]Open DOISearch in Google Scholar
[8. FARFEL Z, FRIEDMAN E. Mental Deficiency in Pseudohypoparathyroidism Type I Is Associated with Ns-Protein Deficiency. Ann Intern Med. 1986;105:197–199. doi: 10.7326/0003-4819-105-2-197.10.7326/0003-4819-105-2-1973089087]Search in Google Scholar
[9. Pseudohypoparathyroidism with osteitis fibrosa cystica: direct demonstration of skeletal responsiveness to parathyroid hormone in cells cultured from bone. Murray TM, Rao LG, Wong MM, Waddell JP, McBroom R, Tam CS, Rosen F, Levine MA. J Bone Miner Res. 1993;8(1):83.842705110.1002/jbmr.56500801118427051]Search in Google Scholar
[10. Pseudohypoparathyroidism: inheritance of deficient receptor-cyclase coupling activity. Farfel Z, Brothers VM, Brickman AS, Conte F, Neer R, Bourne HR. Proc Natl Acad Sci U S A. 1981;78(5):3098.10.1073/pnas.78.5.30983195076265935]Search in Google Scholar
[11. Treatment of pseudohypoparathyroidism with 1 alpha-hydroxyvitamin D3. Furukawa Y, Sohn H, Unakami H, Yumita S. Contrib Nephrol. 1980;22:68.]Search in Google Scholar